Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Gallagher

Showing results (651-660 of 672) with videos related to

Pageof 68
Sort By:
Blood Advances|February 10, 2025
Single-cell dynamics of breakthrough toxicities after anakinra prophylaxis for axicabtagene ciloleucel in lymphomaMatthew J Frigault, Ning Yao, Trisha R Berger, et al.
The Lancet. Infectious Diseases|September 16, 2021
Safety and long-term immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Sierra Leone: a combined open-label, non-randomised stage 1, and a randomised, double-blind, controlled stage 2 trialDavid Ishola, Daniela Manno, Muhammed O Afolabi, et al.
The Journal of Allergy and Clinical Immunology|July 9, 2013
Whole-exome sequencing identifies tetratricopeptide repeat domain 7A (TTC7A) mutations for combined immunodeficiency with intestinal atresiasRui Chen, Silvia Giliani, Gaetana Lanzi, et al.
The Lancet. Infectious Diseases|September 16, 2021
Safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in children in Sierra Leone: a randomised, double-blind, controlled trialMuhammed O Afolabi, David Ishola, Daniela Manno, et al.
The New England Journal of Medicine|March 16, 2012
Prognostic relevance of integrated genetic profiling in acute myeloid leukemiaJay P Patel, Mithat Gönen, Maria E Figueroa, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 22, 2019
The Predictive Performance of a Pneumonia Severity Score in Human Immunodeficiency Virus-negative Children Presenting to Hospital in 7 Low- and Middle-income CountriesKatherine E Gallagher, Maria D Knoll, Chrissy Prosperi, et al.
Blood Advances|January 24, 2022
Humoral and cellular immunogenicity of SARS-CoV-2 vaccines in chronic lymphocytic leukemia: a prospective cohort studyJ Erika Haydu, Jenny S Maron, Robert A Redd, et al.
Nature Communications|June 26, 2021
Temporal trends of SARS-CoV-2 seroprevalence during the first wave of the COVID-19 epidemic in KenyaIfedayo M O Adetifa, Sophie Uyoga, John N Gitonga, et al.
Journal of Dental Research|June 16, 2026
Advancing a Global Oral Health Research AgendaL D Rock, S M Balaji, H Benzian, et al.
Plos One|March 11, 2024
Factors predicting mortality in hospitalised HIV-negative children with lower-chest-wall indrawing pneumonia and implications for managementKatherine E Gallagher, Juliet O Awori, Maria D Knoll, et al.
Pageof 68

Showing results (651-660 of 672) with videos related to

Sort By:
Pageof 68
Blood Advances|February 10, 2025
Single-cell dynamics of breakthrough toxicities after anakinra prophylaxis for axicabtagene ciloleucel in lymphomaMatthew J Frigault, Ning Yao, Trisha R Berger, et al.
The Lancet. Infectious Diseases|September 16, 2021
Safety and long-term immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Sierra Leone: a combined open-label, non-randomised stage 1, and a randomised, double-blind, controlled stage 2 trialDavid Ishola, Daniela Manno, Muhammed O Afolabi, et al.
The Journal of Allergy and Clinical Immunology|July 9, 2013
Whole-exome sequencing identifies tetratricopeptide repeat domain 7A (TTC7A) mutations for combined immunodeficiency with intestinal atresiasRui Chen, Silvia Giliani, Gaetana Lanzi, et al.
The Lancet. Infectious Diseases|September 16, 2021
Safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in children in Sierra Leone: a randomised, double-blind, controlled trialMuhammed O Afolabi, David Ishola, Daniela Manno, et al.
The New England Journal of Medicine|March 16, 2012
Prognostic relevance of integrated genetic profiling in acute myeloid leukemiaJay P Patel, Mithat Gönen, Maria E Figueroa, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 22, 2019
The Predictive Performance of a Pneumonia Severity Score in Human Immunodeficiency Virus-negative Children Presenting to Hospital in 7 Low- and Middle-income CountriesKatherine E Gallagher, Maria D Knoll, Chrissy Prosperi, et al.
Blood Advances|January 24, 2022
Humoral and cellular immunogenicity of SARS-CoV-2 vaccines in chronic lymphocytic leukemia: a prospective cohort studyJ Erika Haydu, Jenny S Maron, Robert A Redd, et al.
Nature Communications|June 26, 2021
Temporal trends of SARS-CoV-2 seroprevalence during the first wave of the COVID-19 epidemic in KenyaIfedayo M O Adetifa, Sophie Uyoga, John N Gitonga, et al.
Journal of Dental Research|June 16, 2026
Advancing a Global Oral Health Research AgendaL D Rock, S M Balaji, H Benzian, et al.
Plos One|March 11, 2024
Factors predicting mortality in hospitalised HIV-negative children with lower-chest-wall indrawing pneumonia and implications for managementKatherine E Gallagher, Juliet O Awori, Maria D Knoll, et al.
Pageof 68